menu
    • menu

    Find Velpatasvir manufacturers, exporters & distributors on PharmaCompass

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Related ProductsRelated Products

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    13

    API Suppliers

    API Suppliers

    0

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    2

    EU WC

    EU WC

    2

    KDMF

    KDMF

    3

    NDC API

    NDC API

    0

    VMF

    NDC API

    8

    Listed Suppliers

    Other Suppliers

    8INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    3

    Others

    FINISHED DOSAGE FORMULATIONS

    18

    FDF Dossiers

    FDF Dossiers

    5

    FDA Orange Book

    FDA (Orange Book)

    8

    Europe

    Europe

    2

    Canada

    Canada

    0

    Australia

    Australia

    1

    South Africa

    South Africa

    2

    Listed Dossiers

    Listed Dossiers

    5DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    107RELATED EXCIPIENT COMPANIES

    168EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    163

    US Patents

    11

    US Exclusivities

    4

    Health Canada Patents

    API REF. PRICE (USD/KG)

    $
    $ 4,164

    GLOBAL SALES INFORMATION

    US Medicaid

    1,037,041,995

    Annual Reports

    41,760

    Regulatory FDF Prices

    NA

    API/FDF Prices: Book a Demo to
    explore the features and consider
    upgrading later

    MARKET PLACE

    9

    API

    0

    FDF

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    7

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 1377049-84-7, Gs-5816, Gs5816, Kcu0c7rs7z, Gs 5816, Methyl ((r)-2-((2s,4s)-2-(5-(2-((2s,5s)-1-((methoxycarbonyl)-l-valyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1h-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl)-2-oxo-1-phenylethyl)carbamate
    Molecular Formula
    C49H54N8O8
    Molecular Weight
    883.0  g/mol
    InChI Key
    FHCUMDQMBHQXKK-CDIODLITSA-N
    FDA UNII
    KCU0C7RS7Z
    Velpatasvir
    Velpatasvir is an orally available inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex, with potential activity against HCV genotypes 1-6. Although the exact mechanism of action of velpatasvir has not yet been completely determined, upon oral administration and intracellular uptake, it appears to bind to domain I of the NS5A protein. This inhibits the activity of the NS5A protein and results in the disruption of the viral RNA replication complex, blockage of viral HCV RNA production, and inhibition of viral replication. NS5A, a zinc-binding and proline-rich hydrophilic phosphoprotein, plays a crucial role in HCV RNA replication. HCV is a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family.
    Velpatasvir is a Hepatitis C Virus NS5A Inhibitor. The mechanism of action of velpatasvir is as a Breast Cancer Resistance Protein Inhibitor, and P-Glycoprotein Inhibitor, and Organic Anion Transporting Polypeptide 1B1 Inhibitor, and Organic Anion Transporting Polypeptide 1B3 Inhibitor, and Organic Anion Transporting Polypeptide 2B1 Inhibitor.
    1 2D Structure

    Velpatasvir

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    methyl N-[(1R)-2-[(2S,4S)-2-[5-[6-[(2S,5S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate
    2.1.2 InChI
    InChI=1S/C49H54N8O8/c1-26(2)41(54-48(60)63-5)47(59)57-27(3)12-17-38(57)45-51-36-16-14-30-20-35-33-15-13-31(19-32(33)25-65-40(35)21-34(30)43(36)53-45)37-22-50-44(52-37)39-18-28(24-62-4)23-56(39)46(58)42(55-49(61)64-6)29-10-8-7-9-11-29/h7-11,13-16,19-22,26-28,38-39,41-42H,12,17-18,23-25H2,1-6H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61)/t27-,28-,38-,39-,41-,42+/m0/s1
    2.1.3 InChI Key
    FHCUMDQMBHQXKK-CDIODLITSA-N
    2.1.4 Canonical SMILES
    CC1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)C8CC(CN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)COC
    2.1.5 Isomeric SMILES
    C[C@H]1CC[C@H](N1C(=O)[C@H](C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)[C@@H]8C[C@@H](CN8C(=O)[C@@H](C9=CC=CC=C9)NC(=O)OC)COC
    2.2 Other Identifiers
    2.2.1 UNII
    KCU0C7RS7Z
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Gs-5816

    2.3.2 Depositor-Supplied Synonyms

    1. 1377049-84-7

    2. Gs-5816

    3. Gs5816

    4. Kcu0c7rs7z

    5. Gs 5816

    6. Methyl ((r)-2-((2s,4s)-2-(5-(2-((2s,5s)-1-((methoxycarbonyl)-l-valyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1h-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl)-2-oxo-1-phenylethyl)carbamate

    7. Methyl [(2s)-1-[(2s,5s)-2-[9-[2-[(2s,4s)-1-[(2r)-2-[(methoxycarbonyl)amino]-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1h-imidazol-5-yl]-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl]-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

    8. Methyl N-[(1r)-2-[(2s,4s)-2-[5-[6-[(2s,5s)-1-[(2s)-2-(methoxycarbonylamino)-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1h-imidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate

    9. Unii-kcu0c7rs7z

    10. Velpatasvir [usan:inn]

    11. Verpatasvir

    12. Methyl ((2s)-1-((2s,5s)-2-(9-(2-((2s,4s)-1-((2r)-2-((methoxycarbonyl)amino)-2-phenylacetyl)-4-(methoxymethyl)pyrrolidin-2-yl)-1h-imidazol-5-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate

    13. Methyl {(2s)-1-[(2s,5s)-2-(9-{2-[(2s,4s)-1-{(2r)-2-[(methoxycarbonyl)amino]-2-phenylacetyl}-4-(methoxymethyl)pyrrolidin-2-yl]-1h-imidazol-5-yl}-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate

    14. Velpatasvir [inn]

    15. Velpatasvir(gs5816)

    16. Velpatasvir [mi]

    17. Velpatasvir [jan]

    18. Velpatasvir; Gs-5816

    19. Velpatasvir [usan]

    20. Velpatasvir [who-dd]

    21. Velpatasvir (jan/usan/inn)

    22. Schembl8756902

    23. Chembl3545062

    24. Schembl19236068

    25. Gtpl11269

    26. Amy4211

    27. Dtxsid70722565

    28. Velpatasvir [orange Book]

    29. Chebi:133009

    30. Epclusa (sofosbuvir + Velpatasvir)

    31. Vosevi Component Velpatasvir

    32. Bcp13813

    33. Epclusa Component Velpatasvir

    34. Ex-a2320

    35. Bdbm50521720

    36. Mfcd28411371

    37. S3724

    38. Velpatasvir Component Of Vosevi

    39. Zinc203686879

    40. Ccg-270553

    41. Cs-5977

    42. Db11613

    43. Velpatasvir Component Of Epclusa

    44. Ncgc00522503-01

    45. Ncgc00522503-02

    46. Ac-28744

    47. As-35237

    48. Hy-12530

    49. Ft-0700879

    50. J3.631.686a

    51. D10806

    52. Gs-5816;gs5816;gs 5816

    53. Vosevi (sofosbuvir + Velpatasvir + Voxilaprevi)

    54. A886410

    55. Q25018296

    56. Carbamic Acid, N-[(1r)-2-[(2s,4s)-2-[5-[1,11-dihydro-2-[(2s,5s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4,3:6,7]naphth[1,2-d]imidazol-9-yl]-1h-imidazol-2-yl]-4-(methoxymethyl)-1-pyrrolidinyl]-2-oxo-1-phenylethyl]-, Methyl Ester

    57. Methyl {(2s)-1-[(2s,5s)-2-(9-{2-[(2s,4s)-1-{(2r)-2-[(methoxycarbonyl)amino]-2-phenylacetyl}-4-(methoxymethyl)pyrrolidin-2-yl]-1h-imidazol-4-yl}-1,11-dihydro[2]benzopyrano[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate

    58. Methyl N-[(1r)-2-[(2s,4s)-2-(5-{6-[(2s,5s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.0?,??.0?,?.0??,??]henicosa-1,3,6,8,10,12,14,16,18-nonaen-17-yl}-1h-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate

    59. Methyl N-[(1r)-2-[(2s,4s)-2-(5-{6-[(2s,5s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.0?,?.01?,1?]henicosa-1,3,6,8,10,12,14,16,18-nonaen-17-yl}-1h-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate

    60. Methyl{(2s)-1-[(2s,5s)-2-(9-{2-[(2s,4s)-1-{(2r)-2-[(methoxycarbonyl)amino]-2-phenylacetyl}-4-(methoxymethyl)pyrrolidin-2-yl]-1h-imidazol-5-yl}-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate

    2.4 Create Date
    2012-11-30
    3 Chemical and Physical Properties
    Molecular Weight 883.0 g/mol
    Molecular Formula C49H54N8O8
    XLogP36.2
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count10
    Rotatable Bond Count13
    Exact Mass882.40646071 g/mol
    Monoisotopic Mass882.40646071 g/mol
    Topological Polar Surface Area193 Ų
    Heavy Atom Count65
    Formal Charge0
    Complexity1690
    Isotope Atom Count0
    Defined Atom Stereocenter Count6
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameEPCLUSA
    Active IngredientSOFOSBUVIR; VELPATASVIR
    CompanyGILEAD SCIENCES INC (Application Number: N208341. Patents: 7964580, 8334270, 8575135, 8580765, 8618076, 8633309, 8735372, 8889159, 8921341, 8940718, 9085573, 9284342, 9757406)

    2 of 2  
    Drug NameVOSEVI
    Active IngredientSOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
    CompanyGILEAD SCIENCES INC (Application Number: N209195. Patents: 7964580, 8334270, 8575135, 8580765, 8618076, 8633309, 8735372, 8889159, 8921341, 8940718, 9085573, 9284342, 9296782, 9585906)

    4.2 Drug Indication

    Velpatasvir is used in combination therapy with other antiviral medications to treat chronic hepatitis C virus (HCV) infected patients with HCV genoptypes 1-6, and to treat HCV and HIV co-infected patients. Depending on the level of cirrhosis or decompensation, combination therapy can also include therapy with [DB00811]. When used in combination with [DB08934] as the combination product Epclusa, Velpatasvir is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis, or in combination with [DB00811] if associated with decompensated cirrhosis.

    FDA Label

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Velpatasvir is a small molecule direct-acting antiviral used in the treatment of hepatitis C in combination with sofosbuvir. Velpatasvir prevents viral replication by inhibiting non-structural protein 5A (NS5A). At a dose 5 times the recommended dose, velpatasvir does not prolong QTc interval to any clinically relevant extent.

    5.2 MeSH Pharmacological Classification

    Antiviral Agents

    Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)

    5.3 FDA Pharmacological Classification
    5.3.1 Active Moiety
    VELPATASVIR
    5.3.2 FDA UNII
    KCU0C7RS7Z
    5.3.3 Pharmacological Classes
    Mechanisms of Action [MoA] - Organic Anion Transporting Polypeptide 2B1 Inhibitors
    5.4 Absorption, Distribution and Excretion

    Absorption

    Oral bioavailability of 25-30%.

    Route of Elimination

    94% excreted in feces with 77% as parent compound. 0.4% excreted in urine.

    Volume of Distribution

    1.4-1.6 L/kg.

    Clearance

    Estimated 0.12 L/h/kg [A19175.

    5.5 Metabolism/Metabolites

    Some metabolism by CYP2B6, CYP2C8, and CYP3A4.

    5.6 Biological Half-Life

    15h.

    5.7 Mechanism of Action

    Velpatasvir's mechanism of action is likely similar to other selective NS5A inhibitors which bind domain I of NS5A consisting of amino acids 33-202. NS5A inhibitors compete with RNA for binding at this site. It is also thought that NS5A inhibitors bind the target during its action in replication when the binding site is exposed. Inhibition of NS5A is also known to produce redistribution of the protein to lipid droplets. The exact role of NS5A in RNA replication is not yet understood although it is known to be an important component.

    API SUPPLIERS

    read-more
    read-more

    01

    Century Pharmaceuticals

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI WW Frankfurt
    Booth #11.0A61
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothCentury has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Century Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Viatris

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Aus. Peptide Conference
    Not Confirmed
    arrow

    Viatris

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Aus. Peptide Conference
    Not Confirmed
    USDMF CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-05-10

    Valid Till : 2026-05-10

    Written Confirmation Number : WC-0015

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Changzhou Pharmaceutical Factory

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Aus. Peptide Conference
    Not Confirmed
    arrow

    Changzhou Pharmaceutical Factory

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Aus. Peptide Conference
    Not Confirmed
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Mangalam Drugs & Organics Ltd

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Aus. Peptide Conference
    Not Confirmed
    arrow

    Mangalam Drugs & Organics Ltd

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Aus. Peptide Conference
    Not Confirmed
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Yuhan Corporation

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Aus. Peptide Conference
    Not Confirmed
    arrow

    Yuhan Corporation

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Aus. Peptide Conference
    Not Confirmed
    USDMF CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 66721-800

    Start Marketing Date : 2016-10-28

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (10kg/10kg)

    Marketing Category : BULK INGREDIENT

     KDMF arrow-down
    ✖

    Registrant Name : Gilead Sciences Korea Ltd.

    Registration Date : 2022-02-17

    Registration Number : Su205-22-ND

    Manufacturer Name : Yuhan Chemical Co., Ltd.

    Manufacturer Address : 162 Cheongwon Industrial Complex 8-gil, Mado-myeon, Hwaseong-si, Gyeonggi-do

     VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Yuhan Corporation

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Aus. Peptide Conference
    Not Confirmed
    arrow

    Yuhan Corporation

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Aus. Peptide Conference
    Not Confirmed
    USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Gilead Sciences Korea Ltd.

    Registration Date : 2022-02-17

    Registration Number : Su205-23-ND

    Manufacturer Name : Yuhan Chemical Co., Ltd.

    Manufacturer Address : 402, 5-ba, Sihwa Industrial Complex, 45 Jiwon-ro, Danwon-gu, Ansan-si, Gyeonggi-do (Seonggok-dong)

     VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Zydus Lifesciences

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Aus. Peptide Conference
    Not Confirmed
    arrow

    Zydus Lifesciences

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Aus. Peptide Conference
    Not Confirmed
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Globe Quimica Ltda

    Brazil

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Aus. Peptide Conference
    Not Confirmed
    arrow

    Globe Quimica Ltda

    Brazil

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Aus. Peptide Conference
    Not Confirmed
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Hetero Drugs

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Aus. Peptide Conference
    Not Confirmed
    arrow

    Hetero Drugs

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Aus. Peptide Conference
    Not Confirmed
    USDMF CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2025-09-03

    Valid Till : 2028-08-08

    Written Confirmation Number : WC-0041

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Aspire Lifesciences Pvt Ltd

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Aus. Peptide Conference
    Not Confirmed
    arrow

    Aspire Lifesciences Pvt Ltd

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Aus. Peptide Conference
    Not Confirmed
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    EU WC

    read-more
    read-moreread-more

    01

    Hetero Drugs

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Hetero Drugs

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Velpatasvir IH

    Date of Issue : 2025-09-03

    Valid Till : 2028-08-08

    Written Confirmation Number : WC-0041

    Address of the Firm : Unit-I, Sy. No. 10, I.D.A, Gaddapotharam (V), Jinnaram (M), Sangareddy District,...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Viatris

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Viatris

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Velpatasvir IH

    Date of Issue : 2023-05-10

    Valid Till : 2026-05-10

    Written Confirmation Number : WC-0015

    Address of the Firm : Unit-8, G.Chodavaram village, Pusapatirega Mandal, Vizianagaram District-535204,...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KDMF

    read-more
    read-moreread-more

    01

    Yuhan Corporation

    South Korea
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Yuhan Corporation

    South Korea
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Velpatasvir

    Registrant Name : Gilead Sciences Korea Ltd.

    Registration Date : 2022-02-17

    Registration Number : Su205-22-ND

    Manufacturer Name : Yuhan Chemical Co., Ltd.

    Manufacturer Address : 162 Cheongwon Industrial Complex 8-gil, Mado-myeon, Hwaseong-si, Gyeonggi-do

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Yuhan Corporation

    South Korea
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Yuhan Corporation

    South Korea
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Velpatasvir

    Registrant Name : Gilead Sciences Korea Ltd.

    Registration Date : 2022-02-17

    Registration Number : Su205-23-ND

    Manufacturer Name : Yuhan Chemical Co., Ltd.

    Manufacturer Address : 402, 5-ba, Sihwa Industrial Complex, 45 Jiwon-ro, Danwon-gu, Ansan-si, Gyeonggi-do (S...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    NDC API

    read-more
    read-moreread-more

    01

    F.I.S. FABBRICA ITALIANA SINTETICI ...

    Italy
    Aus. Peptide Conference
    Not Confirmed
    arrow

    F.I.S. FABBRICA ITALIANA SINTETICI ...

    Italy
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    VELPATASVIR

    NDC Package Code : 48087-0123

    Start Marketing Date : 2015-12-30

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    F.I.S. FABBRICA ITALIANA SINTETICI ...

    Italy
    Aus. Peptide Conference
    Not Confirmed
    arrow

    F.I.S. FABBRICA ITALIANA SINTETICI ...

    Italy
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    VELPATASVIR

    NDC Package Code : 48087-0124

    Start Marketing Date : 2016-11-23

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Yuhan Chemical Inc

    South Korea
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Yuhan Chemical Inc

    South Korea
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    VELPATASVIR

    NDC Package Code : 66721-800

    Start Marketing Date : 2016-10-28

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (10kg/10kg)

    Marketing Category : BULK INGREDIENT

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Listed Suppliers

    read-more
    read-more

    01

    Century Pharmaceuticals

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0A61
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothCentury has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Velpatasvir

    About the Company : Century Pharmaceuticals, established in 1982, has 40 years of experience in manufacturing APIs. It has been supplying APIs produced in-house to several major pharma companies in In...

    Century Pharmaceuticals, established in 1982, has 40 years of experience in manufacturing APIs. It has been supplying APIs produced in-house to several major pharma companies in India and abroad. Its APIs are manufactured in accordance with cGMP, 21CFR part 10 and ICH guidelines. It also produces intermediates and develops new APIs as per the needs of its clients. Century conducts biotechnological research that focuses on human therapeutic proteins. Currently, research is underway to find treatments for asthma, mastocytosis and basophilic leukemia. Century supplies research-grade biotech products and a wide range of animal health products.
    Century Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Aspire Lifesciences Pvt Ltd

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Aspire Lifesciences Pvt Ltd

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Velpatasvir

    About the Company : Aspire group was established in the year 2000 with a motto of quality drug for better health of all. In its journey till date, aspire has developed enormous reputation, consistent ...

    Aspire group was established in the year 2000 with a motto of quality drug for better health of all. In its journey till date, aspire has developed enormous reputation, consistent growth, unique technologies and world class quality healthcare products. Aspire is pioneer in manufacturing and sourcing unique healthcare products. True to the statement, “Where the future started yesterday” with a foresight on the current trends in the healthcare market, Aspire has grown from strength combining its research strength, Human resources and well established quality systems. Aspire has crossed numerous milestones in a comparatively short period since its inception.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Bulat Pharmaceutical

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Bulat Pharmaceutical

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Velpatasvir

    About the Company : Bulat Pharmaceutical is a fast growing pharmaceutical company, founded in the year 2017, Bulat Pharmaceutical is engaged in the manufacturing and sales of high quality APIs and Int...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Changzhou Pharmaceutical Factory

    China
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Changzhou Pharmaceutical Factory

    China
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Velpatasvir

    About the Company : Changzhou Pharmaceutical Factory (CPF) is a subsidiary company of Shanghai Pharma Holdings Co., Ltd., It is headquartered in Changzhou, Jiangsu Province, China. The company was fou...

    Changzhou Pharmaceutical Factory (CPF) is a subsidiary company of Shanghai Pharma Holdings Co., Ltd., It is headquartered in Changzhou, Jiangsu Province, China. The company was founded in 1949 by (Tan Ruiting) with a registered capital of 108 million yuan and the company was restructured as a Changzhou pharmaceutical Factory under the aegis of the Shanghai Pharma Group. The company mainly involves leading pharmaceutical manufacturers a wide range of key Intermediates, Active pharmaceutical ingredients, and Finished Formulations that meet with global standards.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Globe Quimica Ltda

    Brazil
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Globe Quimica Ltda

    Brazil
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Brazil
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Velpatasvir

    About the Company : Globe Quimica S.A. is a major Brazilian API producer, GMP certificated by ANVISA, manufactures more than 20 different API's such as Antiretrovirals, Anxiolytic, Antidepressant, Ant...

    Globe Quimica S.A. is a major Brazilian API producer, GMP certificated by ANVISA, manufactures more than 20 different API's such as Antiretrovirals, Anxiolytic, Antidepressant, Antithrombotic, Analgesic. In 2012 Globe Quimica has started-up its new API plant for Active Ingredients for Oncologic Drugs.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Mangalam Drugs & Organics Ltd

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Mangalam Drugs & Organics Ltd

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Velpatasvir

    About the Company : Mangalam Drugs & Organics Limited started manufacturing APIs and intermediates in 1977 in Gujarat, India. It has a multi-product manufacturing facility and an in-house R&D lab reco...

    Mangalam Drugs & Organics Limited started manufacturing APIs and intermediates in 1977 in Gujarat, India. It has a multi-product manufacturing facility and an in-house R&D lab recognized by the Department of Scientific and Industrial Research, India. Mangalam has established a reputation as a one-stop shop for anti-malaria API and its API manufacturing plant is approved by WHO-GENEVA GMP and EDQM. Mangalam has an agreement with the Clinton Health Access Initiative for the supply of anti-malaria APIs worldwide. It has a wide range of products and is the largest manufacturer of some products in the world. It is among the top companies in Asia.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Viatris

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Viatris

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Velpatasvir

    About the Company : In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (N...

    In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Zydus Lifesciences

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Zydus Lifesciences

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Velpatasvir

    About the Company : Zydus is headquartered in Ahmedabad, India, and ranks 4th in the Indian pharmaceutical industry. The group has manufacturing sites and research facilities spread across five states...

    Zydus is headquartered in Ahmedabad, India, and ranks 4th in the Indian pharmaceutical industry. The group has manufacturing sites and research facilities spread across five states of Gujarat, Maharashtra, Goa, Himachal Pradesh and Sikkim in India and in the US and Brazil. Zydus’ global business has a strong presence in the regulated markets of the US, Europe (France and Spain) and in the high profile markets of Latin America and South Africa. It is also present in a big way in 25 other emerging markets worldwide.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647282600,"product":"VELPATASVIR COPOVIDONE","address":"B-4, IDA,","city":"HYDERABAD, TELANGANA.","supplier":"VIRUJ PHARMACEUTICALS PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"BAGHDAD","customer":"SAMA ALFAYHAA PHARMACEUTICAL INDUSTRIES","customerCountry":"IRAQ","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"4395.5","totalValueFC":"8644.6","currency":"USD","unitRateINR":329442.5,"date":"15-Mar-2022","totalValueINR":"658885","totalValueInUsd":"8644.6","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29349990","bill_no":"4000827","productDescription":"API","marketType":"","country":"IRAQ","selfForZScoreResived":"Pharma Grade","supplierPort":"ARSHIYA-SEZ\/PANVEL","supplierAddress":"B-4, IDA,, HYDERABAD, TELANGANA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1665945000,"product":"VELPATASVIR PREMIX (VELPATASVIR PREMIX)","address":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE","city":"AHMEDABAD","supplier":"ZYDUS LIFESCIENCES LTD","supplierCountry":"INDIA","foreign_port":"YANGON","customer":"ALIDAC HEALTHCARE MYANMAR LIMITE","customerCountry":"MYANMAR","quantity":"10.83","actualQuantity":"10.825","unit":"KGS","unitRateFc":"7289.8","totalValueFC":"77256.6","currency":"USD","unitRateINR":587251.73210161668,"date":"17-Oct-2022","totalValueINR":"6357000","totalValueInUsd":"77256.6","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"4877695","productDescription":"API","marketType":"","country":"MYANMAR","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1689273000,"product":"VELPATASVIR SOLID DISPERSION 50% W\/W","address":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA","city":"VISAKHAPATNAM,ANDHRA PRADESH","supplier":"LAURUS LABS LTD","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"MEEZAN BANK LTD","customerCountry":"PAKISTAN","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"4600","totalValueFC":"113980.5","currency":"USD","unitRateINR":374719.98564000003,"date":"14-Jul-2023","totalValueINR":"9367999.641","totalValueInUsd":"113980.5","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA, VISAKHAPATNAM,ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1699813800,"product":"VELPATASVIR SOLID DISPERSION 50 PCT W\/W","address":"2ND FLOOR, SERENE CHAMBERS,","city":"","supplier":"LAURUS LABS LTD","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"MCB BANK LTD","customerCountry":"PAKISTAN","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"4550","totalValueFC":"112428.3","currency":"USD","unitRateINR":374480,"date":"13-Nov-2023","totalValueINR":"9362000","totalValueInUsd":"112428.3","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"5332746","productDescription":"API","marketType":"","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1700591400,"product":"VELPATASVIR SOLID DISPERSION 50 PCT W\/W","address":"2ND FLOOR, SERENE CHAMBERS,","city":"","supplier":"LAURUS LABS LTD","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"HABIB BANK LTD","customerCountry":"PAKISTAN","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"4550","totalValueFC":"112368.2","currency":"USD","unitRateINR":374280,"date":"22-Nov-2023","totalValueINR":"9357000","totalValueInUsd":"112368.2","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"5484219","productDescription":"API","marketType":"","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706639400,"product":"VELPATASVIR COPOVIDONE (1:1) PHARMACEUTICAL FOR PHARMACEUTICAL RAW MATERIAL AS PER PO","address":"PLOT NO.131,3RD FLOOR,NARMADA","city":"HYDERABAD. AP","supplier":"OPTIMUS DRUGS PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"GLOBAL ADVANCED PHARMACEUTICAL","customerCountry":"EGYPT","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"4000","totalValueFC":"198034.6","currency":"USD","unitRateINR":329179.79999999999,"date":"31-Jan-2024","totalValueINR":"16458990","totalValueInUsd":"198034.6","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"7145490","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.131,3RD FLOOR,NARMADA, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1742409000,"product":"VELPATASVIR COPOVIDONE","address":"PLOT NO.131,3RD FLOOR,NARMADA","city":"HYDERABAD. AP","supplier":"OPTIMUS DRUGS PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"EVA PHARMA FOR PHARMACEUTICALS","customerCountry":"EGYPT","quantity":"50.62","actualQuantity":"50.62","unit":"KGS","unitRateFc":"3500","totalValueFC":"175952.3","currency":"USD","unitRateINR":301077.95337811142,"date":"20-Mar-2025","totalValueINR":"15240566","totalValueInUsd":"175952.3","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"9179837","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.131,3RD FLOOR,NARMADA, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1742495400,"product":"VELPATASVIR SOLID DISPERSION 50 PCT W\/W","address":"2ND FLOOR, SERENE CHAMBERS,","city":"N\/A","supplier":"LAURUS LABS LTD","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"MCB BANK LTD","customerCountry":"PAKISTAN","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"3000","totalValueFC":"74041.3","currency":"USD","unitRateINR":256531.0104,"date":"21-Mar-2025","totalValueINR":"6413275.26","totalValueInUsd":"74041.3","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"9229593","productDescription":"API","marketType":"","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746124200,"product":"(B.NO:VCP25-02 MD:02\/2025 ED:02\/2027)VELPATASVIR COPOVIDONE(1:1)IH,PACK STYLE-200 GM(RAW MATERIAL FOR THE MFG OF FINISH","address":"G-1 DARSHAN FLATS,,RAJESH TOWER RO","city":"VADODARA,GUJARAT","supplier":"ELEMENTS PHARMA INC","supplierCountry":"INDIA","foreign_port":"HO CHI MINH C","customer":"UNDISCLOSED","customerCountry":"VIETNAM","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"5850","totalValueFC":"1151.5","currency":"USD","unitRateINR":490522.45000000001,"date":"02-May-2025","totalValueINR":"98104.49","totalValueInUsd":"1151.5","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"1452153","productDescription":"API","marketType":"","country":"VIETNAM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"G-1 DARSHAN FLATS,,RAJESH TOWER RO, VADODARA,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1747161000,"product":"VELPATASVIR PREMIX IH","address":"HETERO CORPORATE, NO. 7-2-A2,","city":"HYDERABAD","supplier":"HETERO LABS LTD","supplierCountry":"INDIA","foreign_port":"APIIC MAHABOOBNAGAR","customer":"HETERO LABS LTD SEZ UNIT I","customerCountry":"INDIA","quantity":"60.00","actualQuantity":"60","unit":"KGS","unitRateFc":"2367.1","totalValueFC":"139773","currency":"USD","unitRateINR":198479.1548333333,"date":"14-May-2025","totalValueINR":"11908749.29","totalValueInUsd":"139773","indian_port":"SEZ\/Mahaboobnagar","hs_no":"29339990","bill_no":"1788844","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"SEZ\/Mahaboobnagar","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2,, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1755801000,"product":"VELPATASVIR COPOVIDONE","address":"SHED NO F-1, IDA, ROAD NO.6","city":"KUKATPALLY","supplier":"VIRUJ CHEMATRIX PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"BAGDAD, METROPOLITAN","customer":"SAMA ALFAYHAA PHARMACEUTICAL INDUST","customerCountry":"IRAQ","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"4700","totalValueFC":"183254.4","currency":"USD","unitRateINR":400959.29999999999,"date":"22-Aug-2025","totalValueINR":"16038372","totalValueInUsd":"183254.4","indian_port":"JNPT SEZ\/MUMBAI","hs_no":"29349990","bill_no":"4668758","productDescription":"API","marketType":"","country":"IRAQ","selfForZScoreResived":"Pharma Grade","supplierPort":"JNPT SEZ\/MUMBAI","supplierAddress":"SHED NO F-1, IDA, ROAD NO.6, KUKATPALLY","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1659119400,"product":"VELPATASVIR BATCH NO.:RD-VLP-202202201 MFG DATE:FEB.20, 2022EXP DATE: FEB.20, 2024(AS PER ADVANCE LIC)","address":"A-202, 2ND FLOOR, MONDEAL SQUARE BLDG,VEJALPUR:OPP:KARANAVATI CLUB,","city":"S.G. HIGH WAY,AHMEDABAD, GUJARAT.","supplier":"CHANGZHOU PHARMACEUTICAL FACTORY","supplierCountry":"CHINA","foreign_port":"NA","customer":"MEDWISE OVERSEAS PRIVATE LTD","customerCountry":"INDIA","quantity":"1.40","actualQuantity":"1.4","unit":"KGS","unitRateFc":"4000","totalValueFC":"5701","currency":"USD","unitRateINR":"323800","date":"30-Jul-2022","totalValueINR":"453320","totalValueInUsd":"5701","indian_port":"AHMEDABAD AIR","hs_no":"29349990","bill_no":"9799958","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"A-202, 2ND FLOOR, MONDEAL SQUARE BLDG,VEJALPUR:OPP:KARANAVATI CLUB,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1689273000,"product":"VELPATASVIR","address":"VILLAGE NAG KALAN,MAJITHA ROAD,MAJ ITHA","city":"AMRITSAR,PUNJAB","supplier":"YUANFANG CHEMICAL LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"KWALITY PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"3920","totalValueFC":"7941.2","currency":"USD","unitRateINR":"326340.2","date":"14-Jul-2023","totalValueINR":"652679.657","totalValueInUsd":"7941.2","indian_port":"DELHI AIR","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"VILLAGE NAG KALAN,MAJITHA ROAD,MAJ ITHA"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715797800,"product":"PHARMACEUTICALS RAW MATERIAL FOR MFG OF INTERMEDIATE BULK DRUG - VELPATASVIR COPOVIDONE, CAS NO: 1844064-96-5","address":"SHED NO F-1, IDA, ROAD NO.6","city":"KUKATPALLY","supplier":"HANGZHOU QICHUANG CHEMICAL CO LTD","supplierCountry":"CHINA","foreign_port":"N\/A","customer":"MS VIRUJ CHEMATRIX PRIVATE LTD","customerCountry":"INDIA","quantity":"18.00","actualQuantity":"18","unit":"KGS","unitRateFc":"2700","totalValueFC":"49180.6","currency":"USD","unitRateINR":"227745","date":"16-May-2024","totalValueINR":"4099410","totalValueInUsd":"49180.6","indian_port":"JNPT SEZ\/MUMBAI","hs_no":"29349990","bill_no":"1001214","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"ROOM 1204, NO. 46 TIANMUSHAN ROAD, XIHU DISTRICT, HANGZHOU CHINA CN","customerAddress":"SHED NO F-1, IDA, ROAD NO.6"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720204200,"product":"VELPATASVIR (1377049-84-7) (INV NO.ST20240618\/ST20240619)","address":"VILLAGE NAG KALAN,MAJITHA ROAD,MAJ","city":"AMRITSAR,PUNJAB","supplier":"QUANZHOU FORTUNE BIOPHARMA COLTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"KWALITY PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"3300","totalValueFC":"6667.8","currency":"USD","unitRateINR":"278685","date":"06-Jul-2024","totalValueINR":"557370","totalValueInUsd":"6667.8","indian_port":"Delhi Air","hs_no":"29339990","bill_no":"4356231","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"ADD:ROOM2603,RONG TAI\\'AN BUILDING,NO.139 JINHUAI STREET,FENGZE ROAD,FENGZE DISTRICT, QUANZHOU CITY,FUJI CHINA","customerAddress":"VILLAGE NAG KALAN,MAJITHA ROAD,MAJ"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721845800,"product":"VELPATASVIR BATCH NO. : VLP-702-240401","address":"A-202, 2ND FLOOR, MONDEAL SQUARE","city":"S.G. HIGH WAY,AHMEDABAD, GUJARAT.","supplier":"CHANGZHOU PHARMACEUTICAL FACTORY","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"MEDWISE OVERSEAS PRIVATE LTD","customerCountry":"INDIA","quantity":"5.93","actualQuantity":"5.93","unit":"KGS","unitRateFc":"2850","totalValueFC":"17094.4","currency":"USD","unitRateINR":"240967.5","date":"25-Jul-2024","totalValueINR":"1428937.28","totalValueInUsd":"17094.4","indian_port":"Ahmedabad Air","hs_no":"29349990","bill_no":"4693391","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.518 LAODONG EAST ROAD, CHANGZHOU, JIANGSU PROVINCE CHINASDNF CHINA","customerAddress":"A-202, 2ND FLOOR, MONDEAL SQUARE"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1740162600,"product":"VELPATASVIR VELPATASVIR","address":"G\/6, INDL ESTATE, GORWA","city":"GUJARAT","supplier":"HANGZHOU STARSHINE PHARMACEUTICALCO","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"CENTURION LABORATORIES PRIVATE LTD","customerCountry":"INDIA","quantity":"7.94","actualQuantity":"7.94","unit":"KGS","unitRateFc":"2670","totalValueFC":"21391.4","currency":"USD","unitRateINR":"234292.5","date":"22-Feb-2025","totalValueINR":"1860282.45","totalValueInUsd":"21391.4","indian_port":"Bombay Air","hs_no":"29362100","bill_no":"8511182","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"LTDROOM 1005 BULDING 8 DONGYECANAL FORTUNE CENTERNO. 99 SHENHUAROADGON GSHU DISTRICT HANGZHOU CHINA","customerAddress":"G\/6, INDL ESTATE, GORWA"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1754073000,"product":"VELPATASVIR COPOVIDONE, CAS NO: 1844064-96-5 VELPATASVIR COPOVIDONE, CAS NO: 1844064-96-5","address":"SHED NO F-1, IDA, ROAD NO.6","city":"KUKATPALLY","supplier":"HANGZHOU QICHUANG CHEMICAL CO LTD","supplierCountry":"CHINA","foreign_port":"HANGZHOU","customer":"VIRUJ CHEMATRIX PRIVATE LTD","customerCountry":"INDIA","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"3150","totalValueFC":"124963.9","currency":"USD","unitRateINR":"273420","date":"02-Aug-2025","totalValueINR":"10936800","totalValueInUsd":"124963.9","indian_port":"JNPT SEZ\/MUMBAI","hs_no":"29349990","bill_no":"3645334","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HANGZHOU","supplierAddress":"ROOM 1204, NINBO MANSION NO.46 TIANMUSHAN ROAD XIHU DISTRICT, HANGZHOU,ZHEJIANG CN","customerAddress":"SHED NO F-1, IDA, ROAD NO.6"}]
    15-Mar-2022
    22-Aug-2025
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API/FDF Prices: Book a Demo to explore the features and consider upgrading later

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Granulation

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Topical

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Looking for 1377049-84-7 / Velpatasvir API manufacturers, exporters & distributors?

    Velpatasvir manufacturers, exporters & distributors 1

    41

    PharmaCompass offers a list of Velpatasvir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Velpatasvir manufacturer or Velpatasvir supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Velpatasvir manufacturer or Velpatasvir supplier.

    PharmaCompass also assists you with knowing the Velpatasvir API Price utilized in the formulation of products. Velpatasvir API Price is not always fixed or binding as the Velpatasvir Price is obtained through a variety of data sources. The Velpatasvir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

    API | Excipient name

    Velpatasvir

    Synonyms

    1377049-84-7, Gs-5816, Gs5816, Kcu0c7rs7z, Gs 5816, Methyl ((r)-2-((2s,4s)-2-(5-(2-((2s,5s)-1-((methoxycarbonyl)-l-valyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1h-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl)-2-oxo-1-phenylethyl)carbamate

    Cas Number

    1377049-84-7

    Unique Ingredient Identifier (UNII)

    KCU0C7RS7Z

    About Velpatasvir

    Velpatasvir is an orally available inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex, with potential activity against HCV genotypes 1-6. Although the exact mechanism of action of velpatasvir has not yet been completely determined, upon oral administration and intracellular uptake, it appears to bind to domain I of the NS5A protein. This inhibits the activity of the NS5A protein and results in the disruption of the viral RNA replication complex, blockage of viral HCV RNA production, and inhibition of viral replication. NS5A, a zinc-binding and proline-rich hydrophilic phosphoprotein, plays a crucial role in HCV RNA replication. HCV is a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family.

    Velpatasvir Manufacturers

    A Velpatasvir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Velpatasvir, including repackagers and relabelers. The FDA regulates Velpatasvir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Velpatasvir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Velpatasvir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Velpatasvir Suppliers

    A Velpatasvir supplier is an individual or a company that provides Velpatasvir active pharmaceutical ingredient (API) or Velpatasvir finished formulations upon request. The Velpatasvir suppliers may include Velpatasvir API manufacturers, exporters, distributors and traders.

    click here to find a list of Velpatasvir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Velpatasvir KDMF

    In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

    Pharmaceutical companies submit a Velpatasvir Drug Master File in Korea (Velpatasvir KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Velpatasvir. The MFDS reviews the Velpatasvir KDMF as part of the drug registration process and uses the information provided in the Velpatasvir KDMF to evaluate the safety and efficacy of the drug.

    After submitting a Velpatasvir KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Velpatasvir API can apply through the Korea Drug Master File (KDMF).

    click here to find a list of Velpatasvir suppliers with KDMF on PharmaCompass.

    Velpatasvir WC

    A Velpatasvir written confirmation (Velpatasvir WC) is an official document issued by a regulatory agency to a Velpatasvir manufacturer, verifying that the manufacturing facility of a Velpatasvir active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Velpatasvir APIs or Velpatasvir finished pharmaceutical products to another nation, regulatory agencies frequently require a Velpatasvir WC (written confirmation) as part of the regulatory process.

    click here to find a list of Velpatasvir suppliers with Written Confirmation (WC) on PharmaCompass.

    Velpatasvir NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Velpatasvir as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Velpatasvir API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Velpatasvir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Velpatasvir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Velpatasvir NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Velpatasvir suppliers with NDC on PharmaCompass.

    Velpatasvir GMP

    Velpatasvir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Velpatasvir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Velpatasvir GMP manufacturer or Velpatasvir GMP API supplier for your needs.

    Velpatasvir CoA

    A Velpatasvir CoA (Certificate of Analysis) is a formal document that attests to Velpatasvir's compliance with Velpatasvir specifications and serves as a tool for batch-level quality control.

    Velpatasvir CoA mostly includes findings from lab analyses of a specific batch. For each Velpatasvir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Velpatasvir may be tested according to a variety of international standards, such as European Pharmacopoeia (Velpatasvir EP), Velpatasvir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Velpatasvir USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search